ArticleOncoimmunology2022

The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.

Florencia Secchiari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.